Omega Diagnostics Group plc

finnCap have advised Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease on their £1.7m fundraising.

The net proceeds of the Fundraising will be used for working capital purposes and to continue the commercialisation of both versions of the VISITECT® CD4 test.